Comment on Topical Dapsone for Folliculitis Decalvans

Area of Science:

• Dermatology
• Microbiology
• Clinical Research

Background:

• Folliculitis decalvans (FD) is a chronic scalp inflammation causing scarring alopecia.
• Bacterial biofilms may explain FD's persistence and relapse despite antibiotics.
• Novel therapeutic reports in dermatology sometimes yield poor clinical outcomes.

Purpose of the Study:

• To question the efficacy of novel FD treatments when study limitations exist.
• To advocate for stricter criteria in dermatological treatment trials.
• To improve the reliability of clinical research for better patient outcomes.

Main Methods:

• Review of a retrospective study on topical dapsone for FD.
• Clinical experience with a failed trial of 5% dapsone gel in an FD patient.
• Analysis of limitations in published dermatological studies.

Main Results:

• A case of FD worsened with topical dapsone, contradicting positive study reports.
• Identified limitations in a dapsone study include small sample size and retrospective design.
• The need for robust clinical trials to validate new dermatological treatments.

Conclusions:

• Positive study reports for novel dermatological treatments may not translate to clinical practice.
• Stricter criteria for clinical trials and statistical analysis are essential.
• Ensuring genuine clinical utility of drugs prevents physician and patient frustration.